Molecular medicine-based IBD treatment strategies—we take it personally

• Published in: Frontiers in gastroenterology (Lausanne, Switzerland) Vol. 2
• Main Authors: Hentschel, Viktoria, Klaus, Jochen
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 09.08.2023
• Subjects: biomarker; Crohn’s disease; personalized medicine (PM); prediction of response to therapy; ulcerative colitis

In light of potentially aggressive disease courses of either IBD type—CD or UC—marked by frequent flareups or non-subsiding inflammatory activity, effective immunosuppression is key to preventing progressive tissue destruction and permanent disability. However, over-treating patients with a high pro...